August 30, 2021
PENTICTON, BC / ACCESSWIRE / August 25, 2021 / EastWest Bioscience Inc. (“EastWest” or “Company”) (TSXV:EAST), reports that it will not be proceeding with the business […]
August 20, 2021
PENTICTON, BC / ACCESSWIRE / August 20, 2021 / EastWest Bioscience (the “Company” or “EastWest“) (TSXV:EAST) reports that, on July 8, 2020, the US Securities and […]
June 30, 2021
PENTICTON, BC / ACCESSWIRE / June 30, 2021 / EastWest Bioscience Inc. (the “Company” or “EastWest“) (TSXV:EAST), a vertically integrated wellness holding company that owns retail presence […]
April 12, 2021
Penticton, BC / April 12, 2021 / EastWest Bioscience Inc. (TSX.V: EAST) (“EastWest” or the “Company”) and 2747524 Ontario Inc. o/a Cylix Data Group (“Cylix Data”) […]
April 8, 2021
VANCOUVER, BC / ACCESSWIRE / April 8, 2021 / EastWest Bioscience Inc. (the “Company” or “EastWest“) (TSXV:EAST) announces the issuance of 3,777,567 common shares at a price of CDN […]
March 29, 2021
PENTICTON, BC / ACCESSWIRE / March 29, 2021 / EastWest Bioscience (the “Company” or “EastWest“) (TSXV:EAST), a vertically integrated wellness holding company that owns manufacturing facility with retail […]
March 1, 2021
PENTICTON, BC / ACCESSWIRE / March 1, 2021 / EastWest Bioscience (the “Company” or “EastWest“) (TSXV:EAST) provides an operational update on the status of several significant corporate developments. […]
February 5, 2021
VANCOUVER, BC / ACCESSWIRE / February 5, 2021 / EastWest Bioscience (the “Company” or “EastWest”) (TSXV:EAST) announces, subject to its stock option plan, the grant of 1,720,000 […]
February 4, 2021
PENTICTON, BC / ACCESSWIRE / February 2, 2021 / Ms. Ciska Asriel issues this press release pursuant to Part 3 – Early Warning Requirements of National Instrument 62-103 with […]